Literature DB >> 24385011

From nonalcoholic Fatty liver disease to hepatocellular carcinoma: a systems understanding.

Damjana Rozman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24385011     DOI： 10.1007/s10620-013-2998-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

Authors:  Ahmad Al-Serri; Quentin M Anstee; Luca Valenti; Valerio Nobili; Julian B S Leathart; Paola Dongiovanni; Julia Patch; Anna Fracanzani; Silvia Fargion; Christopher P Day; Ann K Daly
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

Review 2.  Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.

Authors:  Pierre Nahon; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2012-05-16       Impact factor: 25.083

Review 3.  Genomic aspects of NAFLD pathogenesis.

Authors:  Adviti Naik; Rok Košir; Damjana Rozman
Journal:  Genomics       Date:  2013-03-29       Impact factor: 5.736

Review 4.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 5.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

6.  Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Craig D Fisher; Jonathan P Jackson; Rhiannon N Hardwick; D Dean Billheimer; Walter T Klimecki; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-07-07       Impact factor: 3.922

7.  Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.

Authors:  John D Clarke; Petr Novak; April D Lake; Petia Shipkova; Nelly Aranibar; Donald Robertson; Paul L Severson; Michael D Reily; Bernard W Futscher; Lois D Lehman-McKeeman; Nathan J Cherrington
Journal:  Dig Dis Sci       Date:  2013-09-19       Impact factor: 3.199

8.  Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.

Authors:  Julia Starmann; Maria Fälth; Walter Spindelböck; Katja-Lauren Lanz; Carolin Lackner; Kurt Zatloukal; Michael Trauner; Holger Sültmann
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

9.  Molecular Interactions between NAFLD and Xenobiotic Metabolism.

Authors:  Adviti Naik; Aleš Belič; Ulrich M Zanger; Damjana Rozman
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

10.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

Authors:  Yujin Hoshida; Sebastian M B Nijman; Masahiro Kobayashi; Jennifer A Chan; Jean-Philippe Brunet; Derek Y Chiang; Augusto Villanueva; Philippa Newell; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Stacey Gabriel; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701
  10 in total
  10 in total

Review 1.  Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Geyza Nogueira de Almeida Armiliato; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  FXR and liver carcinogenesis.

Authors:  Xiong-fei Huang; Wei-yu Zhao; Wen-dong Huang
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

Review 3.  Dietary approach in the treatment of nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Luciana Costa Silva; Maria de Lourdes Abreu Ferrari; Aloísio Sales da Cunha; Flaviano Dos Santos Martins; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-10-28

4.  Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.

Authors:  Silvia M Ferolla; Cláudia A Couto; Luciana Costa-Silva; Geyza N A Armiliato; Cristiano A S Pereira; Flaviano S Martins; Maria de Lourdes A Ferrari; Eduardo G Vilela; Henrique O G Torres; Aloísio S Cunha; Teresa C A Ferrari
Journal:  Nutrients       Date:  2016-06-28       Impact factor: 5.717

Review 5.  Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges.

Authors:  Jonathan Michael Harnoss; Moritz Johannes Strowitzki; Praveen Radhakrishnan; Lisa Katharina Platzer; Julian Camill Harnoss; Thomas Hank; Jun Cai; Alexis Ulrich; Martin Schneider
Journal:  Hypoxia (Auckl)       Date:  2015-01-30

6.  Escherichia coli Affects Expression of Circadian Clock Genes in Human Hepatoma Cells.

Authors:  Urša Kovač; Zala Žužek; Lucija Raspor Dall'Olio; Katka Pohar; Alojz Ihan; Miha Moškon; Damjana Rozman; Marjanca Starčič Erjavec
Journal:  Microorganisms       Date:  2021-04-17

7.  The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.

Authors:  Sara Ebrahimi-Mousavi; Seyed Moayed Alavian; Amir Ali Sohrabpour; Fatemeh Dashti; Kurosh Djafarian; Ahmad Esmaillzadeh
Journal:  BMC Gastroenterol       Date:  2022-03-07       Impact factor: 3.067

Review 8.  Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.

Authors:  Jian Wu
Journal:  Oncotarget       Date:  2016-07-05

9.  Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.

Authors:  Mauro Piacentini; Andrea Baiocchini; Franca Del Nonno; Gerry Melino; Nickolai A Barlev; Federica Rossin; Manuela D'Eletto; Laura Falasca
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 10.  Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.

Authors:  Kazuki Takakura; Tsunekazu Oikawa; Yoichi Tomita; Yusuke Mizuno; Masanori Nakano; Chisato Saeki; Yuichi Torisu; Masayuki Saruta
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.